Large-scale Data To Understand Person-centred Outcomes In Cancer Survivors
Funder
National Health and Medical Research Council
Funding Amount
$1,163,471.00
Summary
Although the majority of people with cancer in Australia now survive long-term, little is known about long-term “person-centred outcomes” for cancer survivors - including mental health, disability, pain and quality of life. This project will use data from >70,000 cancer survivors and >190,000 people without cancer from the general population to generate new knowledge on person-centred outcomes, for different cancer types and over time, to inform and improve health and healthcare.
An Individual-level Study Of Suicide Method Substitution Over Time
Funder
National Health and Medical Research Council
Funding Amount
$218,122.00
Summary
This study will explore patterns of suicide methods _ e.g., whether people who attempt suicide by hanging make subsequent attempts in the following month, and, if so, whether they use the same or different methods. It will track anonymised patients who have been hospitalised for a suicide attempt in 3 Australian states to determine the extent, method and outcome of any subsequent attempts. The study will inform questions about ïbest betsÍ in terms of restricting access to means of suicide.
The structure and dynamics of social contact for human disease transmission models. The methodological advances of this project will enable new insights in important social research. They will not only add significantly to national capacity in the modelling of complex social systems but they will also yield practical scientific outcomes in a significant policy domain in Australia and overseas. In Australia, response to diseases such as HIV, HCV and TB need new approaches, and the threat of pan ....The structure and dynamics of social contact for human disease transmission models. The methodological advances of this project will enable new insights in important social research. They will not only add significantly to national capacity in the modelling of complex social systems but they will also yield practical scientific outcomes in a significant policy domain in Australia and overseas. In Australia, response to diseases such as HIV, HCV and TB need new approaches, and the threat of pandemic influenza is significant. Read moreRead less
Osteoporotic Fracture-Mortality Association And The Effect Of Anti-osteoporosis Treatment: A Multinational Study
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
Osteoporosis burden is due primarily to osteoporotic fractures resulting in economic and public health burden, increased disability, further fracture risk and more importantly early death. However, it remains under-treated although treatment reduces the number of fractures and may reduce early death. This study aims to understand which types of fractures result in early death and for which age groups and whether osteoporosis treatment does or does not reduce early death.
Prevention Of Multi-drug Resistant Tuberculosis In A High Prevalence Setting: ‘Connecting The DOTS’ In Vietnam
Funder
National Health and Medical Research Council
Funding Amount
$3,382,020.00
Summary
The close contacts of people with multi-drug resistant tuberculosis (MDR-TB) have a high risk of developing the disease. The V-QUIN MDR-TB Trial will evaluate the effectiveness of an oral antibiotic (levofloxacin) in preventing drug resistant TB among infected household contacts of TB patients. Household contacts from 10 Provinces in Vietnam will be randomly allocated to receive six-months of either levofloxacin or a placebo, and then followed for two years to see if they develop tuberculosis.
Testing And Treatment For Prostate Cancer In Australia: Epidemiology And Modelling
Funder
National Health and Medical Research Council
Funding Amount
$267,886.00
Summary
We aim to use observational data and mathematical modelling to investigate testing and treatment for prostate cancer in Australia. We will incorporate changes in prostate-specific antigen (PSA) testing and in clinical practice to investigate: a) over-diagnosis, being cancer cases diagnosed through PSA testing that would not have been otherwise diagnosed; b) the effect of PSA testing on prostate cancer mortality; and c) mortality and health care use under different PSA test scenarios.